Infertility in transgenic mice overexpressing the bovine growth hormone gene: luteal failure secondary to prolactin deficiency.
Overexpression of growth hormone (GH) in transgenic mice is associated with various degrees of impairment of female reproductive functions. Transgenic PEPCK.bGH mice express high GH levels, and only around 20% of the females will carry gestation to Day 7. The objective of the present study was to investigate luteal function in PEPCK.bGH mice during early pregnancy, when CL are fully dependent on the pituitary. Plasma progesterone levels measured on Days 2 or 7 postcoitum (p.c.) were lower in transgenic than in normal females. In transgenic females with a previous history of infertility, daily injections of 1 mg progesterone starting on Day 2 p.c. significantly increased the proportion of animals pregnant on Day 7. When ovaries from transgenic mice were transplanted into ovariectomized normal littermates, the recipients exhibited normal vaginal cycles and responded to mating by vaginal cytology changes consistent with pseudopregnancy. In contrast, ovariectomized transgenic females bearing transplants of ovaries from normal mice had slightly prolonged estrous cycles and failed to become pseudopregnant after mating. Plasma progesterone levels on Days 2 and 7 p.c. in normal females with transgenic ovaries were not different from plasma progesterone levels measured in normal females into which normal ovaries had been transplanted. Twice-daily injections of 100 micrograms of prolactin (PRL) in saline or in polyvinylpyrrolidone starting on the evening of Day 2 p.c. were able to rescue luteal function. The proportion of PRL-injected transgenic animals that were pregnant on Day 7 was significantly higher than that of saline-injected transgenic controls and resembled the pregnancy rate of normal animals.(ABSTRACT TRUNCATED AT 250 WORDS)
Cecim
M
M
Department of Physiology, Southern Illinois University School of Medicine, Carbondale 62901-6512, USA.
Kerr
J
J
Bartke
A
A
D000818:Animals; D002417:Cattle; D003338:Corpus Luteum / Q000502:physiology*; D005260:Female; D015870:Gene Expression; D013006:Growth Hormone / Q000235:genetics* / Q000502:physiology*; D007247:Infertility, Female / Q000209:etiology*; D051379:Mice; D008822:Mice, Transgenic; D010729:Phosphoenolpyruvate Carboxykinase (GTP) / Q000235:genetics; D011247:Pregnancy; D011374:Progesterone / Q000097:blood / Q000494:pharmacology; D011388:Prolactin / Q000172:deficiency* / Q000494:pharmacology; D011555:Pseudopregnancy
D011374:Progesterone; D011388:Prolactin; D013006:Growth Hormone; D010729:Phosphoenolpyruvate Carboxykinase (GTP)